Always 2 sides to every issue, this debate has full scientific research behind it, here you go guys:
http://www.evolutionary.org/gw-501516-cardarine-cancer
Sometimes we forget we are in the steroid world, and there are innate risks in everything we do - especially in our industry. No one discusses the cancer dangers of tren, or liver cancer dangers of anadrol, but we are jumping on 1 particular drug as dangerous because it's a "hear-say" argument.
Oral Steroids and cancer:
http://www.ncbi.nlm.nih.gov/pubmed/15849280
We report two very different cases of adult male bodybuilders who developed
hepatocellular adenomas following AAS abuse. The first patient was asymptomatic but had two large liver lesions which were detected by ultrasound studies after routine medical examination. The
second patient was admitted to our hospital with acute renal failure and ultrasound (US) studies showed mild hepatomegaly with several very close hyperecogenic nodules in liver, concordant with adenomas at first diagnosis. In both cases the patients have evolved favourably and the tumours have shown a tendency to regress after the withdrawal of AAS.
http://www.ncbi.nlm.nih.gov/pubmed/15495253
"Thirty-six FA cases and 97 non-FA cases with both nonhematologic disorders and acquired aplastic anemia (non-FA AA) were identified. The most common androgens were oxymetholone, methyltestosterone, and danazol. Hepatocellular carcinomas (HCC) were more often associated with oxymetholone and methyltestosterone, while adenomas were associated with danazol. Tumors were reported in six patients who received only parenteral and not oral androgens. FA patients were younger than non-FA patients when androgen use was initiated, and the FA patients developed tumors at younger ages. Non-AA patients were treated with androgens for longer periods of time, compared with FA and non-FA AA patients.
All patients on anabolic androgenic steroids are at risk of liver tumors, regardless of underlying diagnosis."